By Elias Schisgall
NRC Health's board of directors authorized a $60 million stock buyback program.
The healthcare company, also known as National Research, said the share repurchase authorization is valid through March 31, 2028.
Write to Elias Schisgall at elias.schisgall@wsj.com
(END) Dow Jones Newswires
March 09, 2026 16:47 ET (20:47 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.